CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 45 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 3.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,385,292 | +4.5% | 832,348 | 0.0% | 0.00% | +50.0% |
Q2 2023 | $5,152,234 | +60.8% | 832,348 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $3,204,540 | +24.2% | 832,348 | 0.0% | 0.00% | +100.0% |
Q4 2022 | $2,580,279 | -22.9% | 832,348 | -0.1% | 0.00% | -50.0% |
Q3 2022 | $3,348,000 | -17.5% | 832,932 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $4,056,000 | -26.7% | 832,932 | +35.0% | 0.00% | 0.0% |
Q1 2022 | $5,534,000 | -14.6% | 616,903 | +7.2% | 0.00% | 0.0% |
Q4 2021 | $6,480,000 | -57.9% | 575,538 | -37.6% | 0.00% | -66.7% |
Q3 2021 | $15,399,000 | -24.9% | 922,100 | -0.1% | 0.01% | -25.0% |
Q2 2021 | $20,493,000 | – | 922,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OUP Management Co., LLC | 2,937,615 | $19,006,369 | 42.74% |
Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $129,161,626 | 41.24% |
Vida Ventures Advisors, LLC | 3,931,818 | $25,438,862 | 39.38% |
TCG Crossover Management, LLC | 2,040,816 | $13,204,079 | 1.94% |
Affinity Asset Advisors, LLC | 1,018,091 | $6,587,049 | 1.85% |
BVF INC/IL | 9,103,054 | $58,896,759 | 1.59% |
Sio Capital Management, LLC | 756,891 | $4,897,085 | 1.52% |
ACUTA CAPITAL PARTNERS, LLC | 323,349 | $2,092,068 | 1.40% |
EcoR1 Capital, LLC | 5,618,779 | $36,353,500 | 1.23% |
GENERAL ATLANTIC, L.P. | 9,681,818 | $62,641,362 | 0.97% |